China will allow doctors to practice in multiple locations, subject to approval by health authorities, Shanghai Securities News reported Wednesday. The new policy is aimed at optimizing the country’s health resources. Also, the central government will continue to support privately funded hospitals, the report said. Fosun Pharmaceutical (Group) Co. Ltd. (600196.CN), Kangmei Pharmaceutical Co. Ltd. (600518.CN) and related entities have been acquiring stakes in hospitals, it said.
– Contact HKEJ at [email protected]